Reversible leukoencephalopathy associated with cerebral amyloid angiopathy

Neurology

Volumn 62, Issue 3, 2004, Pages 494-497

  Oh, U ^a   Gupta, R ^b   Krakauer, J W ^c   Khandji, A G ^c   Chin, S S ^c   Elkind, Mitchell S V ^c,d,e  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c Och Spine at New York Presbyterian Hospitals   (United States)

^d Taub Institute for Research on Alzheimer's Disease and the Aging Brain and the Gertrude H Sergievsky Center   (United States)

^e NEUROLOGICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOSIDERIN;

AGED; ARTICLE; BRAIN EDEMA; CASE REPORT; CEREBRAL AMYLOID ANGIOPATHY LEUKOENCEPHALOPATHY; DISEASE ASSOCIATION; DISEASE COURSE; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; GRANULOMATOUS INFLAMMATION; HUMAN; INFLAMMATION; LEUKOENCEPHALOPATHY; MALE; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REVERSIBLE LEUKOENCEPHALOPATHY; VASCULAR AMYLOIDOSIS; WHITE MATTER;

EID: 1042288154     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000106951.94624.DF     Document Type: Article

References (10)

1. Greenberg SM. Cerebral amyloid angiopathy. Prospects for clinical diagnosis and treatment. Neurology 1998;51:690-694.
2. Gray F, Dubas F, Roullet E, Escourolle R. Leukoencephalopathy in diffuse hemorrhagic cerebral amyloid angiopathy. Ann Neurol 1985;18:54-59.
3. Hinchey J, Chaves C, Appignani B, et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med 1996;334:494-500.
4. Caulo M, Tampieri D, Brassard R, Guiot MC, Melanson D. Cerebral amyloid angiopathy presenting as nonhemorrhagic diffuse encephalopathy: neuropathologic and neuroradiologic manifestation in one case. AJNR Am J Neuroradiol 2001;22:1072-1076.
5. Osumi AK, Tien RD, Felsberg GJ, Rosenbloom M. Cerebral amyloid angiopathy presenting as a mass lesion. AJNR Am J Neuroradiol 1995;16:911-915.
6. Briceno CE, Lothar R, Bernstein M. Cerebral amyloid angiopathy presenting as a mass lesion. Stroke 1987;18:234-239.
7. Eng JA, Frosch MP, Greenberg SM. Cerebral amyloid angiopathy-related inflammation, subacute cognitive decline, and reversible white matter changes. Stroke 2003;34:275. Abstract 100.
8. Sarazin M, Amarenco P, Mikol J, Dimitri D, Lot G, Bousser G. Reversible leukoencephalopathy in cerebral amyloid angiopathy presenting as subacute dementia. Eur J Neurol 2002;9:353-358.
9. Silbert PL, Bartleson JD, Gary MM, et al. Cortical petechial hemorrhage, leukoencephalopathy, and subacute dementia associated with seizures due to cerebral amyloid angiopathy. Mayo Clin Proc 1995;70:477-480.
10. Fountain NB, Lopez BS. Control of primary angiitis of the CNS associated with cerebral amyloid angiopathy by cyclophosphamide alone. Neurology 1999;52:660-662.